A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 31, Issue 9, 2012, Pages 942-949

  Shah, Rupal J ^a   Bellamy, Scarlett L ^a   Localio, A Russell ^a   Wickersham, Nancy ^b   Diamond, Joshua M ^a   Weinacker, Ann ^c   Lama, Vibha N ^d   Bhorade, Sangeeta ^e   Belperio, John A ^f   Crespo, Maria ^g   Demissie, Ejigayehu ^a   Kawut, Steven M ^a,b   Wille, Keith M ^h   Lederer, David J ⁱ   Lee, James C ^a   Palmer, Scott M ^j   Orens, Jonathan ^k   Reynolds, John ^l   Shah, Ashish ^k   Wilkes, David S ^l   Ware, Lorraine B ^b   Christie, Jason D ^a   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ New York Presbyterian Columbia University Medical Center   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

acute lung injury; biomarkers; lung transplantation; primary graft dysfunction

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; SURFACTANT PROTEIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; LUNG INJURY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES;

EID: 84864929093     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.05.001     Document Type: Article

References (32)

1. J.D. Christie, M. Carby, R. Bag, P. Corris, M. Hertz, D. Weill ISHLT Working Group on Primary Lung Graft Dysfunction Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition A consensus statement of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 24 2005 1454 1459
2. J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010 J Heart Lung Transplant 29 2010 1104 1118
3. J.C. Lee, J.D. Christie, S. Keshavjee Primary graft dysfunction: definition, risk factors, short- and long-term outcomes Semin Respir Crit Care Med 31 2010 161 171
4. S.A. Daud, R.D. Yusen, B.F. Meyers Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome Am J Respir Crit Care Med 175 2007 507 513
5. J.D. Christie, S. Bellamy, L.B. Ware Construct validity of the definition of primary graft dysfunction after lung transplantation J Heart Lung Transplant 29 2010 1231 1239
6. T. Oto, A.P. Griffiths, B.J. Levvey, D.V. Pilcher, T.J. Williams, G.I. Snell Definitions of primary graft dysfunction after lung transplantation: differences between bilateral and single lung transplantation J Thorac Cardiovasc Surg 132 2006 140 147
7. M.S. Pepe, T. Cai, G. Longton Combining predictors for classification using the area under the receiver operating characteristic curve Biometrics 62 2006 221 229
8. P. Nahid, J. Saukkonen, W.R. Mac Kenzie National Institutes of Health; Centers for Disease Control and Prevention CDC/NIH Workshop Tuberculosis biomarker and surrogate endpoint research roadmap Am J Respir Crit Care Med 184 2011 972 979 15
9. J.D. Christie, N. Robinson, L.B. Ware Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction Am J Respir Crit Care Med 175 2007 69 74
10. M. Covarrubias, L.B. Ware, S.M. Kawut Lung Transplant Outcomes Group Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation Am J Transplant 7 2007 2573 2578
11. J.D. Christie, C.V. Shah, S.M. Kawut Lung Transplant Outcomes Group Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction Am J Respir Crit Care Med 180 2009 1010 1015
12. A. Pelaez, S.D. Force, A.A. Gal Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation Am J Transplant 10 2010 900 907
13. Sims MW, Beers MF, Ahya VN, et al. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest 201;140:489-96.
14. J.D. Christie, R.M. Kotloff, A. Pochettino Clinical risk factors for primary graft failure following lung transplantation Chest 124 2003 1232 1241
15. J.D. Christie, D. Van Raemdonck, M. de Perrot ISHLT Working Group on Primary Lung Graft Dysfunction Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods J Heart Lung Transplant 24 2005 1451 1453
16. A. van de Stolpe, P.T. van der Saag Intercellular adhesion molecule-1 J Mol Med (Berl) 74 1996 13 33
17. H.R. Flori, L.B. Ware, D. Glidden, M.A. Matthay Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation Pediatr Crit Care Med 4 2003 315 321
18. C.S. Calfee, M.D. Eisner, P.E. Parsons NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury Intensive Care Med 35 2009 248 257
19. D. Hartl, M. Griese Surfactant protein D in human lung diseases Eur J Clin Invest 36 2006 423 435
20. A. Bierhaus, P.M. Humpert, M. Morcos Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 2005 876 886
21. C.S. Calfee, M.M. Budev, M.A. Matthay Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation J Heart Lung Transplant 26 2007 675 680
22. C.L. Lau, Y. Zhao, J. Kim Enhanced fibrinolysis protects against lung ischemia-reperfusion injury J Thorac Cardiovasc Surg 137 2009 1241 1248
23. L.B. Ware, X. Fang, M.A. Matthay Protein C and thrombomodulin in human acute lung injury Am J Physiol Lung Cell Mol Physiol 285 2003 L514 L521
24. H. Janes, M.S. Pepe Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting Am J Epidemiol 168 2008 89 97
25. M.W. McIntosh, M.S. Pepe Combining several screening tests: optimality of the risk score Biometrics 58 2002 657 664
26. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12
27. J.D. Christie, J.S. Sager, S.E. Kimmel Impact of primary graft failure on outcomes following lung transplantation Chest 127 2005 161 165
28. J.D. Christie, R.M. Kotloff, V.N. Ahya The effect of primary graft dysfunction on survival after lung transplantation Am J Respir Crit Care Med 171 2005 1312 1316
29. C.M. Burton, M. Iversen, N. Milman Outcome of lung transplanted patients with primary graft dysfunction Eur J Cardiothorac Surg 31 2007 75 82
30. A.C. Justice, K.E. Covinsky, J.A. Berlin Assessing the generalizability of prognostic information Ann Intern Med 130 1999 515 524
31. T.E. King Jr, J.A. Tooze, M.I. Schwarz, K.R. Brown, R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 2001 1171 1181
32. K. Krenn, W. Klepetko, S. Taghavi, G. Lang, B. Schneider, S. Aharinejad Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction Am J Transplant 7 2007 700 706